VORICONAZOLE FOR INJECTION

fresenius kabi canada ltd🇨🇦 Health Canada

Approval Id: 03ab17474beeccf2
Drug Approval Canada Name: VORICONAZOLE FOR INJECTION
Product Name: VORICONAZOLE FOR INJECTION
Status: Marketed
Status Date: 2021-09-01
Original Market Date: 2021-09-01
Din: 02493829
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 08:14.08
Atc Original: J02AC03 VORICONAZOLE
Atc Name: j 02 ac 03
Aig Number: 0150242002
Company Name: fresenius kabi canada ltd
Company Address: 165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8

VORICONAZOLE

200 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

03ab17474beeccf2

Type

Standard